Breakthrough gene therapy offers cure for a rare bleeding disorder heamophilia
BBC - 21-Jul-2022Trial results were positive but cautioned the use until proven safe and effective
Join the club for FREE to access the whole archive and other member benefits.
Health care provider.
We provide a wide range of routine and specialist health services and we aim to deliver world class healthcare to our patients. To do so, we combine world class expertise with leading healthcare that is local, patient-focused and friendly.
Last year our highly skilled healthcare teams provided treatment and care for over a million patients and achieved some of the best clinical outcomes in England. Our mortality rates have been the best among England's hospital trusts for many years. Our goal is to continue excelling and to be in the top 10 per cent in the UK for clinical research, scientific medical research and teaching outcomes.
Visit website: https://www.royalfree.nhs.uk/about-us/
royal-free-london-nhs-foundation-trust
See also: NHS - UK National Health Service, publicly funded healthcare system in England
Details last updated 29-Nov-2019
Heamatologist and Professor of Haemophilia and Haemostasis at University College London
Trial results were positive but cautioned the use until proven safe and effective
Lab results to the right doctors at the right time can improve patient's outcome